CD8A and melanoma: In addition, the activated CD8+ T cells recognizing TRP-2 were significantly increased in Ccl21a-KO tumors than in WT tumors, suggesting that host-derived CCL21-Ser has a suppressive effect on anti-melanoma immunity.